Non-alcoholic Fatty Liver Disease: Growing Burden, Adverse Outcomes and Associations
Open accessThe DOI matches its Crossref record; 121 of the 121 references it cites were found in a registry or an index.
Abstract
Nonalcoholic fatty liver disease (NAFLD) is a systemic disorder with a complex multifactorial pathogenesis and heterogenous clinical manifestations. NAFLD, once believed to be an innocuous condition, has now become the most common cause of chronic liver disease in many countries worldwide. NAFLD is already highly prevalent in the general population, and owing to a rising incidence of obesity and diabetes mellitus, the incidence of NAFLD and its impact on global healthcare are expected to increase in the future. A subset of patients with NAFLD develops progressive liver disease leading to cirrhosis, hepatocellular carcinoma, and liver failure. NAFLD has emerged as one of the leading causes of cirrhosis and hepatocellular carcinoma in recent years. Moreover, HCC can occur in NAFLD even in absence of cirrhosis. Compared with the general population, NAFLD increases the risk of liver-related, cardiovascular and all-cause mortality. NAFLD is bidirectionally associated with metabolic syndrome. NAFLD increases the risk and contributes to aggravation of the pathophysiology of atherosclerosis, cardiovascular diseases, diabetes mellitus, and chronic kidney disease. In addition, NAFLD is linked to colorectal polyps, polycystic ovarian syndrome, osteoporosis, obstructive sleep apnea, stroke, and various extrahepatic malignancies. Extended resection of steatotic liver is associated with increased risk of liver failure and mortality. There is an increasing trend of NAFLD-related cirrhosis requiring liver transplantation, and the recurrence of NAFLD in such patients is almost universal. This review discusses the growing burden of NAFLD, its outcomes, and adverse associations with various diseases.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
ZHOU, Y. J., LI, Y. Y., NIE, Y. Q., HUANG, C. M., & CAO, C. Y. (2012) · Journal of Digestive Diseases · doi:10.1111/j.1751-2980.2011.00571.x · Cited by 78 · cited 1×
“Zhou et al.(55), 2012 3,543 community-based cohort study of Chinese adult subjects 4 years Ultrasound Patients with NAFLD had ;3-fold higher rates of all-cause and CVD mortality than those without NAFLD”
BackgroundRetractedYounossi, Z. M., Koenig, A. B., Abdelatif, D., Fazel, Y., Henry, L., & Wymer, M. (2016) · Hepatology · doi:10.1002/hep.28431 · Cited by 10,781 · cited 3×
“A recent meta-analysis also revealed occurrence of fibrosis progression in 41% of NASH patients, with 20% of them identified as being rapid progressors.(5) Yet”
BackgroundInfluentialVernon, G., Baranova, A., & Younossi, Z. M. (2011) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2011.04724.x · Cited by 3,074 · cited 1×
“NAFLD, once believed to be an innocuous condition, has emerged as the leading cause of chronic liver disease in many countries worldwide.(2,3) NAFLD is now pandemic worldwide and its prevalence has increased considerably over the last two decades.”
BackgroundAngulo, P., Kleiner, D. E., Dam-Larsen, S., Adams, L. A., Bjornsson, E. S., Charatcharoenwitthaya, P., Mills, P. R., Keach, J. C., Lafferty, H. D., Stahler, A., et al. (2015) · Gastroenterology · doi:10.1053/j.gastro.2015.04.043 · Cited by 2,987 · cited 5×
“Death was most commonly due to malignancy and CVD.(50) Using the third set of NHANES data, Ong et al.”
BackgroundInfluentialThe Natural History of Nonalcoholic Fatty Liver Disease: A Population-Based Cohort Study
Adams, L. A., Lymp, J. F., St. Sauver, J., Sanderson, S. O., Lindor, K. D., Feldstein, A., & Angulo, P. (2005) · Gastroenterology · doi:10.1053/j.gastro.2005.04.014 · Cited by 2,890
Prevalence of sleep-disordered breathing in the general population: the HypnoLaus study
Heinzer, R., Vat, S., Marques-Vidal, P., Marti-Soler, H., Andries, D., Tobback, N., Mooser, V, Preisig, M., Malhotra, A., Waeber, G., et al. (2015) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(15)00043-0 · Cited by 2,481 · cited 1×
“30).(91) This association is related to the degree of nocturnal hypoxemia caused by repetitive upper airway obstruction during sleep.”
BackgroundEstes, C., Razavi, H., Loomba, R., Younossi, Z., & Sanyal, A. J. (2018) · Hepatology · doi:10.1002/hep.29466 · Cited by 2,399 · cited 1×
“The projected increase in the prevalence of NASH is 63%, which will cause a 168% increase in the number of patients with decompensated cirrhosis, and a 137% increase in the numbers of patients developing HCC by 2030.(18) Thus, with growing prevalence rates of NAFLD affecting both adults and children, it is likely to e…”
BackgroundLong-term follow-up of patients with NAFLD and elevated liver enzymes
Ekstedt, M., Franzén, L. E., Mathiesen, U. L., Thorelius, L., Holmqvist, M., Bodemar, G., & Kechagias, S. (2006) · Hepatology · doi:10.1002/hep.21327 · Cited by 2,302 · cited 4×
“Ekstedt et al.(58), 2006 129 Swedish biopsy-proven NAFLD patients 13.”
BackgroundInfluentialEkstedt, M., Hagström, H., Nasr, P., Fredrikson, M., Stål, P., Kechagias, S., & Hultcrantz, R. (2015) · Hepatology · doi:10.1002/hep.27368 · Cited by 2,287 · cited 16×
“Ekstedt et al.(53), 2015 229 Swedish patients with biopsy-proven NAFLD 26.”
BackgroundInfluentialDulai, P. S., Singh, S., Patel, J., Soni, M., Prokop, L. J., Younossi, Z., Sebastiani, G., Ekstedt, M., Hagstrom, H., Nasr, P., et al. (2017) · Hepatology · doi:10.1002/hep.29085 · Cited by 1,965
Wong, R. J., Aguilar, M., Cheung, R., Perumpail, R. B., Harrison, S. A., Younossi, Z. M., & Ahmed, A. (2015) · Gastroenterology · doi:10.1053/j.gastro.2014.11.039 · Cited by 1,819
Singh, S., Allen, A. M., Wang, Z., Prokop, L. J., Murad, M. H., & Loomba, R. (2015) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2014.04.014 · Cited by 1,748 · cited 1×
“3 years).(29) A very slow rate of progression of SS may partly account for the discrepancy between clinical and histological studies, as such patients may die from other causes before developing advanced liver disease.”
Loomba, R., & Sanyal, A. J. (2013) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2013.171 · Cited by 1,641 · cited 2×
“According to current estimate, the global prevalence of NAFLD among the general population may be as high as one billion.(2) In a recent meta-analysis of 86 studies,”
BackgroundPowell, E. E., Cooksley, G. W. E., Hanson, R., Searle, J., Halliday, J. W., & Powell, L. W. (1990) · Hepatology · doi:10.1002/hep.1840110114 · Cited by 1,473
Bugianesi, E., Leone, N., Vanni, E., Marchesini, G., Brunello, F., Carucci, P., Musso, A., De Paolis, P., Capussotti, L., Salizzoni, M., et al. (2002) · Gastroenterology · doi:10.1053/gast.2002.34168 · Cited by 1,439 · cited 1×
“In contrast to studies based on needle biopsy samples, explants from CC patients undergoing LT have revealed steatosis (80%) and ballooning (70%) in a significant proportion.(37) A study from India that assessed explants from patients with CC revealed NASH to be the etiology in 63% patients.”
ResultNon-alcoholic fatty liver disease and risk of incident cardiovascular disease: A meta-analysis
Targher, G., Byrne, C. D., Lonardo, A., Zoppini, G., & Barbui, C. (2016) · Journal of Hepatology · doi:10.1016/j.jhep.2016.05.013 · Cited by 1,424 · cited 5×
“However, the observational design of the studies included does not prove that NAFLD causes CVD.(78) Thus, there seems to be little doubt that NAFLD is associated with increased incidence and prevalence of CVD, some controversies surround as to whether NAFLD by itself is associated with increased CVD mortality.”
BackgroundInfluentialVauthey, J.-N., Pawlik, T. M., Ribero, D., Wu, T.-T., Zorzi, D., Hoff, P. M., Xiong, H. Q., Eng, C., Lauwers, G. Y., Mino-Kenudson, M., et al. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2005.05.3074 · Cited by 1,300 · cited 1×
“5).(106) In conclusion, major hepatic resection of steatotic liver, particularly in patients with NASH, is associated with increased risk of liver failure and death.”
BackgroundMusso, G., Gambino, R., Cassader, M., & Pagano, G. (2011) · Annals of Medicine · doi:10.3109/07853890.2010.518623 · Cited by 1,293
Obesity and nonalcoholic fatty liver disease: From pathophysiology to therapeutics
Polyzos, S. A., Kountouras, J., & Mantzoros, C. S. (2019) · Metabolism · doi:10.1016/j.metabol.2018.11.014 · Cited by 1,211
Younossi, Z. M., Stepanova, M., Afendy, M., Fang, Y., Younossi, Y., Mir, H., & Srishord, M. (2011) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2011.03.020 · Cited by 1,073
McPherson, S., Hardy, T., Henderson, E., Burt, A. D., Day, C. P., & Anstee, Q. M. (2015) · Journal of Hepatology · doi:10.1016/j.jhep.2014.11.034 · Cited by 1,060 · cited 1×
“6 years.(7,28) In a meta-analysis of 11 studies including 411 patients with paired liver biopsy performed at least 1 year apart, liver fibrosis progression occurred not only in patients with NASH but also in patients with nonalcoholic fatty liver (NAFL), defined as SS alone or associated with mild inflammation.”
BackgroundBelghiti, J., Hiramatsu, K., Benoist, S., Massault, P. P., Sauvanet, A., & Farges, O. (2000) · Journal of the American College of Surgeons · doi:10.1016/s1072-7515(00)00261-1 · Cited by 1,051 · cited 2×
“In a series of 135 patients who had undergone major hepatic resection at the Mayo Clinic, acute liver failure occurred in 14% of patients with fatty liver versus 4% in those with normal liver.104 In a cohort of 478 liver resection patients, Belghiti et al.105 demonstrated that steatosis was an independent risk factor…”
BackgroundThe natural history of nonalcoholic fatty liver: A follow-up study
Teli, M. R., James, O. F. W., Burt, A. D., Bennett, M. K., & Day, C. P. (1995) · Hepatology · doi:10.1002/hep.1840220616 · Cited by 925
Younossi, Z. M., Otgonsuren, M., Henry, L., Venkatesan, C., Mishra, A., Erario, M., & Hunt, S. (2015) · Hepatology · doi:10.1002/hep.28123 · Cited by 802
Kim, D., Kim, R. W., Kim, H. J., & Therneau, T. M. (2013) · Hepatology · doi:10.1002/hep.26156 · Cited by 772 · cited 4×
“NAFLD has been recently associated with sarcopenia which is defined as a generalized, and progressive and loss of skeletal muscle mass, quality, and strength.100,101 Sarcopenia is associated with increased risks and histological severity of NAFLD, independent of obesity and metabolic risk factors.100 In a longitudinal…”
BackgroundInfluentialDecreased Survival of Subjects With Elevated Liver Function Tests During A 28-Year Follow-Up
Söderberg, C., Stål, P., Askling, J., Glaumann, H., Lindberg, G., Marmur, J., & Hultcrantz, R. (2010) · Hepatology · doi:10.1002/hep.23314 · Cited by 754 · cited 1×
“Söderberg et al.(52), 2010 256 Swedish subjects with raised liver enzymes, including 118 biopsy-proven NAFLD 28 years Histology 40% of the 118 NAFLD subjects died during follow-up.”
BackgroundLong-Term Follow-Up of Patients With Nonalcoholic Fatty Liver
Rafiq, N., Bai, C., Fang, Y., Srishord, M., McCullough, A., Gramlich, T., & Younossi, Z. M. (2009) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2008.11.005 · Cited by 729
Wong, R. J., Cheung, R., & Ahmed, A. (2014) · Hepatology · doi:10.1002/hep.26986 · Cited by 723 · cited 1×
“There is growing trend of patients with NASH-related cirrhosis requiring liver transplantation (LT).(14,15) The risk of developing progressive liver disease and associated extrahepatic diseases presents a challenge to the healthcare system to develop effective strategies in order to prevent an exponential increase in…”
BackgroundMusso, G., Gambino, R., Tabibian, J. H., Ekstedt, M., Kechagias, S., Hamaguchi, M., Hultcrantz, R., Hagström, H., Yoon, S. K., Charatcharoenwitthaya, P., et al. (2014) · PLoS Medicine · doi:10.1371/journal.pmed.1001680 · Cited by 720 · cited 6×
“%) than those with SS.”
BackgroundResultInfluentialWong, V. W.-S., Wong, G. L.-H., Choi, P. C.-L., Chan, A. W.-H., Li, M. K.-P., Chan, H.-Y., Chim, A. M.-L., Yu, J., Sung, J. J.-Y., & Chan, H. L.-Y. (2010) · Gut · doi:10.1136/gut.2009.205088 · Cited by 648
Younossi, Z. M., Stepanova, M., Rafiq, N., Makhlouf, H., Younoszai, Z., Agrawal, R., & Goodman, Z. (2011) · Hepatology · doi:10.1002/hep.24268 · Cited by 638 · cited 14×
“Moreover, the association between obesity and cancer risk was small in the absence of NAFLD, suggesting that NAFLD may potentiate obesity-cancer relationship.79 In a cohort study of 129 biopsy-proven NAFLD patients, 5.6% of the patients with NASH died because of extrahepatic malignancy during a mean follow-up of 13.7…”
BackgroundInfluentialIncreased overall mortality and liver-related mortality in non-alcoholic fatty liver disease
Ong, J. P., Pitts, A., & Younossi, Z. M. (2008) · Journal of Hepatology · doi:10.1016/j.jhep.2008.06.018 · Cited by 638 · cited 17×
“Using the third set of NHANES data, Ong et al.(51) found NAFLD to be associated with higher overall (hazard ratio (HR): 1.”
BackgroundMethodInfluentialPiscaglia, F., Svegliati‐Baroni, G., Barchetti, A., Pecorelli, A., Marinelli, S., Tiribelli, C., Bellentani, S., & on behalf of the HCC‐NAFLD Italian Study Group (2016) · Hepatology · doi:10.1002/hep.28368 · Cited by 604 · cited 1×
“However, alarmingly, HCC can develop de novo in patients with NASH in the absence of cirrhosis.(41,42) Kawada et al.”
BackgroundHepatocellular cancer: the impact of obesity, type 2 diabetes and a multidisciplinary team
Dyson, J., Jaques, B., Chattopadyhay, D., Lochan, R., Graham, J., Das, D., Aslam, T., Patanwala, I., Gaggar, S., Cole, M., et al. (2014) · Journal of Hepatology · doi:10.1016/j.jhep.2013.08.011 · Cited by 603 · cited 2×
“A recent large population - based Surveillance, Epidemiology and End Results (known as the SEER) study has demonstrated a 9% annual increase in NAFLD-related HCC between 2004 and 2009.45 Dyson et al.46 noted a nearly 10 - fold increase in NAFLD - related HCC cases in the UK from 2000 to 2010.”
BackgroundInfluentialParadis, V., Zalinski, S., Chelbi, E., Guedj, N., Degos, F., Vilgrain, V., Bedossa, P., & Belghiti, J. (2009) · Hepatology · doi:10.1002/hep.22734 · Cited by 571
Systematic review of risk factors for fibrosis progression in non-alcoholic steatohepatitis
Argo, C. K., Northup, P. G., Al-Osaimi, A. M. S., & Caldwell, S. H. (2009) · Journal of Hepatology · doi:10.1016/j.jhep.2009.03.019 · Cited by 552 · cited 1×
“3 years.(30) A recent meta-analysis also revealed occurrence of fibrosis progression in 41% of NASH patients, with 20% of them identified as being rapid progressors.”
BackgroundNon-alcoholic fatty liver disease and diabetes
Hazlehurst, J. M., Woods, C., Marjot, T., Cobbold, J. F., & Tomlinson, J. W. (2016) · Metabolism · doi:10.1016/j.metabol.2016.01.001 · Cited by 527
The natural history of nonalcoholic fatty liver disease: a clinical histopathological study
Harrison, S. (2003) · The American Journal of Gastroenterology · doi:10.1016/s0002-9270(03)00622-1 · Cited by 482
Kojima, S.-I., Watanabe, N., Numata, M., Ogawa, T., & Matsuzaki, S. (2003) · Journal of Gastroenterology · doi:10.1007/s00535-003-1178-8 · Cited by 455 · cited 2×
“6 years.(7,28) In a meta-analysis of 11 studies including 411 patients with paired liver biopsy performed at least 1 year apart, liver fibrosis progression occurred not only in patients with NASH but also in patients with nonalcoholic fatty liver (NAFL), defined as SS alone or associated with mild inflammation.”
BackgroundSarcopenia is an independent risk factor for non-alcoholic steatohepatitis and significant fibrosis
Koo, B. K., Kim, D., Joo, S. K., Kim, J. H., Chang, M. S., Kim, B. G., Lee, K. L., & Kim, W. (2017) · Journal of Hepatology · doi:10.1016/j.jhep.2016.08.019 · Cited by 440 · cited 2×
“Sarcopenia is associated with increased risks and histological severity of NAFLD, independent of obesity and metabolic risk factors.(100) In a longitudinal study, Kim et al.”
BackgroundLi, L., Liu, D. ‐., Yan, H. ‐., Wang, Z. ‐., Zhao, S. ‐., & Wang, B. (2016) · Obesity Reviews · doi:10.1111/obr.12407 · Cited by 439
NAFLD in Asia—as common and important as in the West
Farrell, G. C., Wong, V. W.-S., & Chitturi, S. (2013) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2013.34 · Cited by 432 · cited 1×
“The changing epidemiology of NAFLD in Asia during the past two decades is well-documented.(4,6,7) NAFLD is strongly associated with metabolic syndrome (MetS), the components of which include hypertension, hyperglycemia, abdominal obesity, and dyslipidemia.”
BackgroundSookoian, S., & Pirola, C. J. (2008) · Journal of Hepatology · doi:10.1016/j.jhep.2008.06.012 · Cited by 406 · cited 1×
“NAFLD has been linked with increased biomarkers of endothelial dysfunction,(62) increased carotid artery intima-media thickness,(63) increased arterial stiffness,(64) coronary artery calcification,(65) and impaired flow-mediated vasodilatation.(66) A recent meta-analysis of 27 studies supported the association of NAFL…”
Nonalcoholic fatty liver disease and chronic vascular complications of diabetes mellitus
Targher, G., Lonardo, A., & Byrne, C. D. (2018) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2017.173 · Cited by 397 · cited 5×
“NAFLD is associated with increased risk of developing DM after adjustment for several metabolic confounders.54,58,59 Two large meta-analyses have confirmed the association between NAFLD and incident T2DM.54 In a prospective study of 129 biopsy-proven NAFLD patients, 78% developed either T2DM (58”
BackgroundInfluentialHepatic steatosis as a potential risk factor for major hepatic resection
Behrns, K. E., Tsiotos, G. G., DeSouza, N. F., Krishna, M. K., Ludwig, J., & Nagorney, D. M. (1998) · Journal of Gastrointestinal Surgery · doi:10.1016/s1091-255x(98)80025-5 · Cited by 393 · cited 1×
“In a series of 135 patients who had undergone major hepatic resection at the Mayo Clinic, acute liver failure occurred in 14% of patients with fatty liver versus 4% in those with normal liver.(104) In a cohort of 478 liver resection patients, Belghiti et al.”
BackgroundAlanine Aminotransferase, γ-Glutamyltransferase, and Incident Diabetes
Fraser, A., Harris, R., Sattar, N., Ebrahim, S., Davey Smith, G., & Lawlor, D. A. (2009) · Diabetes Care · doi:10.2337/dc08-1870 · Cited by 385
Oni, E. T., Agatston, A. S., Blaha, M. J., Fialkow, J., Cury, R., Sposito, A., Erbel, R., Blankstein, R., Feldman, T., Al-Mallah, M. H., et al. (2013) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2013.07.052 · Cited by 352
Wu, S., Wu, F., Ding, Y., Hou, J., Bi, J., & Zhang, Z. (2016) · Scientific Reports · doi:10.1038/srep33386 · Cited by 318 · cited 1×
“66) CVD but not with CVD mortality.(77) However, there was marked heterogeneity among studies and nonuniform definition of important variables, including DM, which could have affected the results of mortality.”
BackgroundAllen, A. M., Hicks, S. B., Mara, K. C., Larson, J. J., & Therneau, T. M. (2019) · Journal of Hepatology · doi:10.1016/j.jhep.2019.08.018 · Cited by 312 · cited 3×
“NAFLD has also been found to be associated with malignancy of the esophagus, stomach, pancreas, kidney, and prostate.(9,54,79) However, concurrent presence of features of MetS and too little available data limit drawing definite conclusions about a causal role of NAFLD in such association.”
BackgroundNonalcoholic fatty liver disease is associated with coronary artery calcification
Kim, D., Choi, S.-Y., Park, E. H., Lee, W., Kang, J. H., Kim, W., Kim, Y. J., Yoon, J.-H., Jeong, S. H., Lee, D. H., et al. (2012) · Hepatology · doi:10.1002/hep.25593 · Cited by 310 · cited 3×
“Kim et al.(65) South Korea 2012 4023 1617 (40.”
InfluentialUSE OF FATTY DONOR LIVER IS ASSOCIATED WITH DIMINISHED EARLY PATIENT AND GRAFT SURVIVAL
Marsman, W. A., Wiesner, R. H., Rodriguez, L., Batts, K. P., Porayko, M. K., Hay, J. E., Gores, G. J., & Krom, R. A. F. (1996) · Transplantation · doi:10.1097/00007890-199611150-00011 · Cited by 302
Dai, W., Ye, L., Liu, A., Wen, S. W., Deng, J., Wu, X., & Lai, Z. (2017) · Medicine · doi:10.1097/md.0000000000008179 · Cited by 268
Obstructive Sleep Apnea, Hypoxia, and Nonalcoholic Fatty Liver Disease
Mesarwi, O. A., Loomba, R., & Malhotra, A. (2019) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201806-1109tr · Cited by 263 · cited 14×
“Intermittent hypoxia can result in oxidative stress, IR, abnormal lipid metabolism, overactivation of the sympathetic nervous system, inflammation, and mitochondrial dysfunction, each of which plays important roles in development and progression of NAFLD.(92) Intermittent hypoxia activates hypoxia-inducible factors, w…”
BackgroundInfluentialHigh prevalence of colorectal neoplasm in patients with non-alcoholic steatohepatitis
Wong, V. W.-S., Wong, G. L.-H., Tsang, S. W.-C., Fan, T., Chu, W. C.-W., Woo, J., Chan, A. W.-H., Choi, P. C.-L., Chim, A. M.-L., Lau, J. Y.-W., et al. (2011) · Gut · doi:10.1136/gut.2011.237974 · Cited by 256 · cited 1×
“Moreover, NASH remained significantly associated with a risk of adenomas and advanced neoplasms after adjusting for demographic and metabolic factors.(81) In a retrospective cohort study on 1,522 subjects who underwent two consecutive colonoscopies between 2003 and 2010, NAFLD was an independent risk factor (OR: 1.”
BackgroundAron-Wisnewsky, J., Minville, C., Tordjman, J., Lévy, P., Bouillot, J.-L., Basdevant, A., Bedossa, P., Clément, K., & Pépin, J.-L. (2012) · Journal of Hepatology · doi:10.1016/j.jhep.2011.04.022 · Cited by 255 · cited 1×
“The chronic intermittent hypoxia in morbidly obese subjects contributes to the severity of hepatic necroinflammation and fibrosis independent of adiposity.(93) Furthermore, NAFLD in patients with OSA is associated with higher CVD risks.”
BackgroundMiele, L., Vallone, S., Cefalo, C., La Torre, G., Di Stasi, C., Vecchio, F. M., D’Agostino, M., Gabrieli, M. L., Vero, V., Biolato, M., et al. (2009) · Journal of Hepatology · doi:10.1016/j.jhep.2009.06.008 · Cited by 249
Haring, R., Wallaschofski, H., Nauck, M., Dörr, M., Baumeister, S. E., & Völzke, H. (2009) · Hepatology · doi:10.1002/hep.23135 · Cited by 245
Caballería, L., Pera, G., Auladell, M. A., Torán, P., Muñoz, L., Miranda, D., Alumà, A., Casas, J. D., Sánchez, C., Gil, D., et al. (2010) · European Journal of Gastroenterology & Hepatology · doi:10.1097/meg.0b013e32832fcdf0 · Cited by 239 · cited 1×
“Caballería et al.(111) Spain 2010 766 198 (25.”
Nonalcoholic Fatty Liver Disease and Metabolic Syndrome
Kim, D., Touros, A., & Kim, W. R. (2018) · Clinics in Liver Disease · doi:10.1016/j.cld.2017.08.010 · Cited by 238 · cited 1×
“NAFLD is strongly associated with metabolic syndrome (MetS), the components of which include hypertension, hyperglycemia, abdominal obesity, and dyslipidemia.(8) However, NAFLD is not merely a hepatic manifestation of MetS but rather both a consequence as well a predecessor of MetS.”
BackgroundYalamanchili, K., Saadeh, S., Klintmalm, G. B., Jennings, L. W., & Davis, G. L. (2010) · Liver Transplantation · doi:10.1002/lt.22004 · Cited by 227 · cited 2×
“Approximately 10% of the patients progressed to advanced fibrosis or cirrhosis in a decade.(110) In conclusion, NAFLD is highly prevalent in the general population, and its prevalence is expected to increase in the coming years.”
Non-alcoholic fatty liver disease in patients with chronic plaque psoriasis
Gisondi, P., Targher, G., Zoppini, G., & Girolomoni, G. (2009) · Journal of Hepatology · doi:10.1016/j.jhep.2009.04.020 · Cited by 225 · cited 1×
“Moreover, data also suggest that the presence of NAFLD may increase severity of psoriasis.(96,97) Future studies are needed to assess whether there is a causal relationship between NAFLD and psoriasis.”
BackgroundCKD and Nonalcoholic Fatty Liver Disease
Targher, G., Chonchol, M. B., & Byrne, C. D. (2014) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2014.05.019 · Cited by 213 · cited 16×
“Moreover, the association between obesity and cancer risk was small in the absence of NAFLD, suggesting that NAFLD may potentiate obesity-cancer relationship.79 In a cohort study of 129 biopsy-proven NAFLD patients, 5.6% of the patients with NASH died because of extrahepatic malignancy during a mean follow-up of 13.7…”
BackgroundInfluentialGenetic predisposition in nonalcoholic fatty liver disease
Sookoian, S., & Pirola, C. J. (2017) · Clinical and Molecular Hepatology · doi:10.3350/cmh.2016.0109 · Cited by 213 · cited 2×
“Apart from components of MetS, genetic polymorphisms, such as PNPLA3 I148M gene and transmembrane 6 superfamily member 2 E167K gene variants, have a significant impact on NAFLD susceptibility and progression.(25) Identification of such variants may help to identify NAFLD patients at higher risk for liver disease progr…”
BackgroundHepatocellular carcinoma arising from non-cirrhotic nonalcoholic steatohepatitis
Kawada, N., Imanaka, K., Kawaguchi, T., Tamai, C., Ishihara, R., Matsunaga, T., Gotoh, K., Yamada, T., & Tomita, Y. (2009) · Journal of Gastroenterology · doi:10.1007/s00535-009-0112-0 · Cited by 204
Li, Z., Xue, J., Chen, P., Chen, L., Yan, S., & Liu, L. (2014) · Journal of Gastroenterology and Hepatology · doi:10.1111/jgh.12428 · Cited by 202 · cited 1×
“The changing epidemiology of NAFLD in Asia during the past two decades is well-documented.(4,6,7) NAFLD is strongly associated with metabolic syndrome (MetS), the components of which include hypertension, hyperglycemia, abdominal obesity, and dyslipidemia.”
BackgroundKim, G., Lee, S., Lee, Y., Jun, J. E., Ahn, J., Bae, J. C., Jin, S., Hur, K. Y., Jee, J. H., Lee, M., et al. (2018) · Hepatology · doi:10.1002/hep.30049 · Cited by 198 · cited 4×
“NAFLD has been recently associated with sarcopenia which is defined as a generalized, and progressive and loss of skeletal muscle mass, quality, and strength.(100,101) Sarcopenia is associated with increased risks and histological severity of NAFLD, independent of obesity and metabolic risk factors.”
BackgroundInfluentialDassanayake, A. S., Kasturiratne, A., Rajindrajith, S., Kalubowila, U., Chakrawarthi, S., De Silva, A. P., Makaya, M., Mizoue, T., Kato, N., Wickremasinghe, A. R., et al. (2009) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2009.05831.x · Cited by 185 · cited 1×
“Dassanayake et al.(118) Sri Lanka 2009 2985 974 (32.”
Rocha, A. L. L., Faria, L. C., Guimarães, T. C. M., Moreira, G. V., Cândido, A. L., Couto, C. A., & Reis, F. M. (2017) · Journal of Endocrinological Investigation · doi:10.1007/s40618-017-0708-9 · Cited by 183 · cited 1×
“95) and the presence of NAFLD among them is associated with hyperandrogenism, in addition to IR and adiposity.(89) The prevalence of NAFLD among women with PCOS is estimated to vary from 15% to 55%, whereas amongst the reproductive-aged women with NAFLD, the prevalence of PCOS is as high as 71%.”
BackgroundSilent non-alcoholic fatty liver disease—a clinical–histological study
Sorrentino, P., Tarantino, G., Conca, P., Perrella, A., Terracciano, M. L., Vecchione, R., Gargiulo, G., Gennarelli, N., & Lobello, R. (2004) · Journal of Hepatology · doi:10.1016/j.jhep.2004.07.010 · Cited by 183 · cited 1×
“Clinical-histological study has revealed silent cirrhosis in 10% (8/80) of NAFLD patients with normal liver enzymes.(32) Around 9–25% of patients with NASH progress to cirrhosis over a period of 10–20 years.”
BackgroundMahfood Haddad, T., Hamdeh, S., Kanmanthareddy, A., & Alla, V. M. (2017) · Diabetes & Metabolic Syndrome: Clinical Research & Reviews · doi:10.1016/j.dsx.2016.12.033 · Cited by 182 · cited 3×
“In a prospective study including a total of 25,800 subjects, Hadda et al.102 found an increased frequency of CVA in NAFLD compared to the controls.”
BackgroundInfluentialVerrijken, A., Francque, S., Mertens, I., Prawitt, J., Caron, S., Hubens, G., Van Marck, E., Staels, B., Michielsen, P., & Van Gaal, L. (2014) · Hepatology · doi:10.1002/hep.26510 · Cited by 181 · cited 1×
“elevated levels of which are related to increased risk of myocardial infarction.(75) In a recent prospective study among patients with clinical indication of coronary angiogram (n = 612), the presence of NAFLD was associated with severity of coronary artery stenosis and need for coronary intervention.”
BackgroundSahebkar, A., Chew, G. T., & Watts, G. F. (2014) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.2014.876992 · Cited by 180 · cited 5×
“Several studies have unequivocally demonstrated a strong association between NAFLD and increased risk of CVD. NAFLD has been linked with increased biomarkers of endothelial dysfunction,62 increased carotid artery intima-media thickness,63 increased arterial stiffness,64 coronary artery calcification,65 and impaired fl…”
BackgroundInfluentialNonalcoholic fatty liver disease: Definitions, risk factors, and workup
Puri, P., & Sanyal, A. J. (2012) · Clinical Liver Disease · doi:10.1002/cld.81 · Cited by 174 · cited 1×
“Nonalcoholic fatty liver disease (NAFLD) is characterized by accumulation of fat in $5% of hepatocytes in the absence of significant alcohol consumption (<30 g/day for men and <20 g/day for women) or secondary causes of hepatic steatosis.(1) Histologically, the spectrum of NAFLD ranges from simple steatosis (SS) that…”
BackgroundCryptogenic cirrhosis: Clinicopathologic findings at and after liver transplantation
Ayata, G., Gordon, F. D., Lewis, W. D., Pomfret, E., Pomposelli, J. J., Jenkins, R. L., & Khettry, U. (2002) · Human Pathology · doi:10.1053/hupa.2002.129419 · Cited by 173 · cited 2×
“It seems that the features of NASH usually regress concurrently with fibrosis progression.(34,35) In contrast to studies based on needle biopsy samples, explants from CC patients undergoing LT have revealed steatosis (80%) and ballooning (70%) in a significant proportion.”
BackgroundResultYounossi, Z. M., Otgonsuren, M., Venkatesan, C., & Mishra, A. (2013) · Metabolism · doi:10.1016/j.metabol.2012.08.005 · Cited by 169
Obesity, Nonalcoholic Fatty Liver Disease and Adipocytokines Network in Promotion of Cancer
Divella, R., Mazzocca, A., Daniele, A., Sabbà, C., & Paradiso, A. (2019) · International Journal of Biological Sciences · doi:10.7150/ijbs.29599 · Cited by 167 · cited 1×
“The prevalence of NAFLD is about 50–90% in obese subjects.(19) The pooled prevalence of NAFLD in patients with T2DM is 59.”
BackgroundRelationship of Non-alcoholic Fatty Liver Disease With Cholecystectomy in the US Population
Ruhl, C. E., & Everhart, J. E. (2013) · The American Journal of Gastroenterology · doi:10.1038/ajg.2013.70 · Cited by 165 · cited 1×
“Ruhl et al.(113) USA 2013 12232 2446 (20.”
Chang, Y., Jung, H.-S., Yun, K. E., Cho, J., Cho, Y. K., & Ryu, S. (2013) · American Journal of Gastroenterology · doi:10.1038/ajg.2013.349 · Cited by 163
Käräjämäki, A. J., Pätsi, O.-P., Savolainen, M., Kesäniemi, Y. A., Huikuri, H., & Ukkola, O. (2015) · PLOS ONE · doi:10.1371/journal.pone.0142937 · Cited by 153
Robbins, J. A., Nelson, J. C., Rautaharju, P. M., & Gottdiener, J. S. (2003) · The American Journal of Medicine · doi:10.1016/j.amjmed.2003.07.014 · Cited by 153 · cited 1×
“Notably, the duration of the QT interval is a predictor for CVD death in the general population, and a prolonged QT interval increases the risk of cardiac arrhythmias and sudden cardiac death.(74) NAFLD contributes to the prothrombotic state by increas-”
BackgroundPrognosis of patients with a diagnosis of fatty liver--a registry-based cohort study.
Jepsen, P., Vilstrup, H., Mellemkjær, L., Thulstrup, A. M., Olsen, J. H., Baron, J. A., & Sørensen, H. T. (2003) · PubMed · Cited by 152
Emerging Liver–Kidney Interactions in Nonalcoholic Fatty Liver Disease
Musso, G., Cassader, M., Cohney, S. J., Pinach, S., Saba, F., & Gambino, R. (2015) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2015.08.005 · Cited by 150 · cited 1×
“Furthermore, CKD may aggravate NAFLD through uremic toxins, intestinal dysbiosis, altered gut-barrier function, and alterations in glucocorticoid metabolism.(87) Interestingly, there is evidence to suggest that in patients with NASH, improvement in liver histology by lifestyle modification leads to improved kidney fun…”
BackgroundKim, H. C., Kim, D. J., & Huh, K. B. (2008) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2008.09.012 · Cited by 147
van der Voort, E. A. M., Koehler, E. M., Dowlatshahi, E. A., Hofman, A., Stricker, B. H., Janssen, H. L. A., Schouten, J. N. L., & Nijsten, T. (2014) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2013.10.044 · Cited by 145 · cited 2×
“van der Voort et al.(95) Netherlands 2014 2292 779 (34.”
BackgroundLi, M., Xu, Y., Xu, M., Ma, L., Wang, T., Liu, Y., Dai, M., Chen, Y., Lu, J., Liu, J., et al. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-3010 · Cited by 137 · cited 1×
“5-fold increased odds of osteoporotic fractures among men.(99) A recent meta-analysis of six studies has revealed that obese children with NAFLD are more susceptible to osteoporosis than children with only obesity.”
BackgroundWong, V. W., Wong, G. L., Yeung, J. C., Fung, C. Y., Chan, J. K., Chang, Z. H., Kwan, C. T., Lam, H., Limquiaco, J., Chim, A. M., et al. (2016) · Hepatology · doi:10.1002/hep.28253 · Cited by 135
Recurrent Disease Following Liver Transplantation for Nonalcoholic Steatohepatitis Cirrhosis
Malik, S. M., deVera, M. E., Fontes, P., Shaikh, O., Sasatomi, E., & Ahmad, J. (2009) · Liver Transplantation · doi:10.1002/lt.21943 · Cited by 133 · cited 1×
“NAFLD is an independent predictor of occurrence of post-LT MetS that increases the risk of steatosis in the graft liver.(109,110) Within a few months of LT, steatosis developed in 60–100% of the patients and NASH in 10–40% of the patients.”
BackgroundTakuma, Y. (2010) · World Journal of Gastroenterology · doi:10.3748/wjg.v16.i12.1436 · Cited by 128 · cited 7×
“%) having large (mean size 3.5 cm) and multifocal HCC.44 Several reports have confirmed the increasing burden of NAFLD - related HCC worldwide.”
BackgroundInfluentialPersistent Nonalcoholic Fatty Liver Disease Increases Risk for Carotid Atherosclerosis
Sinn, D. H., Cho, S. J., Gu, S., Seong, D., Kang, D., Kim, H., Yi, B.-K., Paik, S. W., Güallar, E., Cho, J., et al. (2016) · Gastroenterology · doi:10.1053/j.gastro.2016.06.001 · Cited by 120 · cited 14×
“Moreover, the association between obesity and cancer risk was small in the absence of NAFLD, suggesting that NAFLD may potentiate obesity-cancer relationship.79 In a cohort study of 129 biopsy-proven NAFLD patients, 5.6% of the patients with NASH died because of extrahepatic malignancy during a mean follow-up of 13.7…”
BackgroundInfluentialFotbolcu, H., Yakar, T., Duman, D., Karaahmet, T., Tigen, K., Çevik, C., Kurtoğlu, Ü., & Dindar, İ. (2010) · PubMed · Cited by 118
Exercise training reverses endothelial dysfunction in nonalcoholic fatty liver disease
Pugh, C. J. A., Sprung, V. S., Kemp, G. J., Richardson, P., Shojaee-Moradie, F., Umpleby, A. M., Green, D. J., Cable, N. T., Jones, H., & Cuthbertson, D. J. (2014) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00306.2014 · Cited by 116
Steatosis in Liver Transplantation: Current Limitations and Future Strategies
Linares, I., Hamar, M., Selzner, N., & Selzner, M. (2018) · Transplantation · doi:10.1097/tp.0000000000002466 · Cited by 114 · cited 3×
“It has emerged as one of the leading causes of cirrhosis and HCC in recent years and is a growing indication for LT. NAFLD is associated with various extrahepatic diseases and increased risk of all-cause mortality.”
BackgroundInfluentialPost hepatectomy liver failure – A comprehensive review of current concepts and controversies
Ray, S., Mehta, N. N., Golhar, A., & Nundy, S. (2018) · Annals of Medicine and Surgery · doi:10.1016/j.amsu.2018.08.012 · Cited by 114 · cited 1×
“However, extended liver resection may lead to the development of progressive liver failure in the postoperative period which is associated with very high mortality rate.(103) Steatotic liver have poor ability to regenerate and reduced tolerance against ischemic injury.”
BackgroundTreatment and survival of non-alcoholic steatohepatitis associated hepatocellular carcinoma
Weinmann, A., Alt, Y., Koch, S., Nelles, C., Düber, C., Lang, H., Otto, G., Zimmermann, T., Marquardt, J. U., Galle, P. R., et al. (2015) · BMC Cancer · doi:10.1186/s12885-015-1197-x · Cited by 111 · cited 1×
“In a study from Germany, where 1119 patients with HCC treated in an 11 year period were retrospectively analyzed, the overall survival among the patients with NASH-related HCC (n = 45) was lower compared to those with HCC of other etiologies.(49) However, it appears that the worse natural history in such patients is n…”
ResultTargher, G., Rossini, M., & Lonardo, A. (2015) · Endocrine · doi:10.1007/s12020-015-0640-8 · Cited by 110
Nonalcoholic Fatty Liver Disease and Incident Cardiac Events
Zeb, I., Li, D., Budoff, M. J., Katz, R., Lloyd‐Jones, D. M., Agatston, A. A., Blumenthal, R. S., Blaha, M. J., Blankstein, R., Carr, J. J., et al. (2016) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2016.01.070 · Cited by 109 · cited 1×
“Zeb et al.(122), 2016 4,119 USA adult subjects, including 728 NAFLD, without CVD at baseline Median 7.”
BackgroundNonalcoholic Fatty Liver Disease Is Associated With QT Prolongation in the General Population
Hung, C., Tseng, P., Tu, C., Chen, C.-C., Liao, W., Lee, Y., Chiu, H., Lin, H., Ho, Y., Yang, W., et al. (2015) · Journal of the American Heart Association · doi:10.1161/jaha.115.001820 · Cited by 107 · cited 1×
“NAFLD has also been reported as independently associated with QT prolongation.(73) Notably, the duration of the QT interval is a predictor for CVD death in the general population, and a prolonged QT interval increases the risk of cardiac arrhythmias and sudden cardiac death.”
BackgroundExtrahepatic Manifestations of Nonalcoholic Fatty Liver Disease
VanWagner, L. B., & Rinella, M. E. (2016) · Current Hepatology Reports · doi:10.1007/s11901-016-0295-9 · Cited by 105 · cited 2×
“Various studies have suggested that NAFLD can accelerate the development and progression of CKD independent of traditional risk factors.(10,84,85) A recent meta-analysis, that included near 64,000 subjects, found that NAFLD was associated with an approximately 2-fold increase in risk of both prevalent (OR: 2.”
BackgroundNon-alcoholic Fatty Liver Disease in Lean Subjects: Characteristics and Implications
Kumar, R., & Mohan, S. (2017) · Journal of Clinical and Translational Hepatology · doi:10.14218/jcth.2016.00068 · Cited by 102 · cited 1×
“In Asia, NAFLD can occur in lean subjects with central obesity, which may be partly because of a higher metabolic activity of visceral fat and genetic predisposition, such as the patatin-like phospholipase domain-containing 3 (PNPLA3) polymorphism.(24,25) It is worth noting that a wide variation in clinical presentati…”
BackgroundSelf-citationReview of nonalcoholic fatty liver disease in women with polycystic ovary syndrome
Kelley, C. E. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i39.14172 · Cited by 100 · cited 1×
“The prevalence of NAFLD among women with PCOS is estimated to vary from 15% to 55%, whereas amongst the reproductive-aged women with NAFLD, the prevalence of PCOS is as high as 71%.(90)”
BackgroundMinville, C., Hilleret, M., Tamisier, R., Aron‐Wisnewsky, J., Clément, K., Trocmé, C., Borel, J., Levy, P. A., Zarski, J., & Pépin, J. (2013) · CHEST Journal · doi:10.1378/chest.13-0938 · Cited by 97 · cited 2×
“Minville et al.(94) have recently demonstrated that in patients with OSA, hepatic steatosis was independently associated with endothelial dysfunction after adjustment for confounders.”
BackgroundLee, Y. I., Lim, Y., & Park, H. S. (2011) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2011.06816.x · Cited by 97 · cited 1×
“A large cohort study (n = 5517) from Korea has found a two-fold increase in the occurrence of colorectal adenoma and a three-fold increase in the risk of colorectal cancer in patients with NAFLD compared to controls.(80) Another study revealed that among NAFLD, patients with NASH have a higher prevalence of adenomas (…”
ResultNonalcoholic fatty liver disease and decreased bone mineral density: is there a link?
Targher, G., Lonardo, A., & Rossini, M. (2015) · Journal of Endocrinological Investigation · doi:10.1007/s40618-015-0315-6 · Cited by 92 · cited 1×
“Several studies have demonstrated that NAFLD patients have lower bone mineral density compared to non-NAFLD subjects.(98) In a study from China, NAFLD was independently associated with a ;2.”
ResultThe Relationship Between Arterial Stiffness and Nonalcoholic Fatty Liver Disease
Lee, Y., Shim, J., Moon, B. S., Shin, Y.-H., Jung, D., Lee, J., & Lee, H.-R. (2011) · Digestive Diseases and Sciences · doi:10.1007/s10620-011-1819-3 · Cited by 82
Epidemic of non-alcoholic fatty liver disease and hepatocellular carcinoma
Said, A., & Ghufran, A. (2017) · World Journal of Clinical Oncology · doi:10.5306/wjco.v8.i6.429 · Cited by 81 · cited 1×
“8 % over 3 years.(40) However, alarmingly, HCC can develop de novo in patients with NASH in the absence of cirrhosis.”
BackgroundHuang, K. ‐., Leu, H. ‐., Wang, Y. ‐., Luo, J. ‐., Lin, H. ‐., Lee, F. ‐., Chan, W. ‐., Lin, J. ‐., & Chang, F. ‐. (2013) · Colorectal Disease · doi:10.1111/codi.12172 · Cited by 80 · cited 1×
“98) for adenoma formation after a negative baseline colonoscopy.(82) The adenoma group had a higher prevalence of NAFLD than the non-adenoma group (55.”
BackgroundSingal, A. K., Salameh, H. M., Kuo, Y., & Wiesner, R. H. (2014) · Transplantation · doi:10.1097/tp.0000000000000048 · Cited by 80 · cited 1×
“Compared to other etiologies of cirrhosis, the risk of CKD and requirement of simultaneous liver-kidney transplantation are greater in patients with NASH-related cirrhosis.(86) Furthermore, CKD may aggravate NAFLD through uremic toxins, intestinal dysbiosis, altered gut-barrier function, and alterations in glucocortic…”
BackgroundWong, S., Ting, Y., & Chan, W. (2018) · JGH Open · doi:10.1002/jgh3.12070 · Cited by 77 · cited 14×
“Moreover, patients with NAFLD-related HCC had a shorter survival time, more cardiovascular events, and more cancer-related mortality than patients without NAFLD.(48) In a study from Germany, where 1119 patients with HCC treated in an 11 year period were retrospectively analyzed, the overall survival among the patients…”
ResultInfluentialCho, E. J., Kwack, M. S., Jang, E. S., You, S. J., Lee, J.-H., Kim, Y. J., Yoon, J.-H., & Lee, H.-S. (2011) · Digestion · doi:10.1159/000333210 · Cited by 77 · cited 1×
“Another study from a hepatitis B - endemic area in Korea has also demonstrated an increasing proportion of NAFLD - related HCC cases over time.(47) Moreover, patients with NAFLD-related HCC had a shorter survival time, more cardiovascular events, and more cancer-related mortality than patients without NAFLD.”
BackgroundHu, J., Xu, Y., He, Z., Zhang, H., Lian, X., Zhu, T., Liang, C., & Li, J. (2017) · Oncotarget · doi:10.18632/oncotarget.22755 · Cited by 61
Karabay, C. Y., Kocabay, G., Kalaycı, A., Çolak, Y., Oduncu, V., Akgün, T., Kalkan, S., Güler, A., & Kırma, C. (2013) · European Journal of Gastroenterology & Hepatology · doi:10.1097/meg.0000000000000008 · Cited by 55 · cited 1×
“Studies in patients with NAFLD have shown abnormal left ventricular morphology and diastolic dysfunction when compared with controls.(70,71) Various factors have been implicated in the causation of left ventricular dysfunction in NAFLD, including hyperinsulinemiainduced myocyte growth and interstitial fibrosis, altera…”
BackgroundNayak, N. C., Vasdev, N., Saigal, S., & Soin, A. S. (2009) · Human Pathology · doi:10.1016/j.humpath.2009.06.021 · Cited by 53 · cited 1×
“Moreover, the recurrence of steatosis in the allograft of CC patients is remarkably high (100% in 5 years).(39) Therefore, NASH-cirrhosis cases appear to constitute a significant proportion of patients previously labelled as CC.”
BackgroundSuomela, E., Oikonen, M., Virtanen, J. M., Parkkola, R. K., Jokinen, E. V., Laitinen, T. P., nen, N. H.-K. A. H. O., Kähönen, M. A. P., Lehtimäki, T. J., Taittonen, L. M., et al. (2014) · Annals of Medicine · doi:10.3109/07853890.2014.966752 · Cited by 51 · cited 1×
“Suomela et al.(112) Finland 2015 1621 246 (15.”
A case–control study of non-alcoholic fatty liver disease in breast cancer
Bilici, A. E., Özgüroğlu, M., Mihmanlı, İ., et al. (2007) · Medical Oncology · doi:10.1007/s12032-007-0034-8 · Cited by 45 · cited 1×
“In a case-control study, NAFLD was found to have a significant association with breast cancer.(83) NAFLD has also been found to be associated with malignancy of the esophagus, stomach, pancreas, kidney, and prostate.”
BackgroundCohort profile: the Trivandrum non-alcoholic fatty liver disease (NAFLD) cohort
Chalmers, J., Ban, L., Balakumaran, L. K., Edwards, K., Grove, J. I., Aithal, G. P., & Shenoy, K. T. (2019) · BMJ Open · doi:10.1136/bmjopen-2018-027244 · Cited by 44 · cited 1×
“Chalmers et al.(17) India 2019 2158 1075 (49.”
Influence of Fatty Liver on the Severity and Clinical Outcome in Acute Pancreatitis
Xu, C., Qiao, Z., Lu, Y., Zhang, D., Jia, Z., Zhuang, X., Shi, Y., Xu, T., Xing, L., & Shen, J. (2015) · PLoS ONE · doi:10.1371/journal.pone.0142278 · Cited by 41 · cited 1×
“A recent study demonstrated that the presence of NAFLD at admission portends a higher risk of severe and moderately severe AP, as well as a higher risk of organ failure.(11) Themechanism by which NAFLD exacerbates pancreatitis remains unclear.”
BackgroundNayak, N. C., Jain, D., Vasdev, N., Gulwani, H. V., Saigal, S., & Soin, A. S. (2012) · European Journal of Gastroenterology & Hepatology · doi:10.1097/meg.0b013e32835643f1 · Cited by 39 · cited 1×
“Many of the patients with CC have features of MetS in varying proportions.(35,36) However, needle biopsy studies have failed to demonstrate histological features of NASH in patients with CC.”
BackgroundCai, W., Wu, X., Zhang, B., Miao, L., Sun, Y.-P., Zou, Y., & Yao, H. (2013) · Arquivos Brasileiros de Endocrinologia & Metabologia · doi:10.1590/s0004-27302013000800006 · Cited by 36 · cited 1×
“Cai et al.(117) China 2013 10605 3906 (36.”
Tung, T., Shen, H.-C., Zhao, Z., Hu, Y., & Chen, Y. (2014) · Clinical Interventions in Aging · doi:10.2147/cia.s59538 · Cited by 23
Sun, Y., Dai, W., Liang, Y., Yang, P., Yang, Q., Liang, M., & Xia, N. (2019) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s192256 · Cited by 15 · cited 1×
“A recent meta-analysis of six studies has revealed that obese children with NAFLD are more susceptible to osteoporosis than children with only obesity.(13) The potential contribution of NAFLD to development of osteoporosis warrants further study.”
BackgroundHard clinical outcomes in patients with NAFLD
Kumar, R. K. (2013) · Hepatology International · doi:10.1007/s12072-013-9455-y · Cited by 13 · cited 2×
“NAFLD has also been found to be associated with malignancy of the esophagus, stomach, pancreas, kidney, and prostate.(9,54,79) However, concurrent presence of features of MetS and too little available data limit drawing definite conclusions about a causal role of NAFLD in such association.”
BackgroundSelf-citation
Cited by
Petrovic, A., Igrec, D., Rozac, K., Bojanic, K., Kuna, L., Kolaric, T. O., Mihaljevic, V., Sikora, R., Smolic, R., Glasnovic, M., et al. (2023) · Current Issues in Molecular Biology · doi:10.3390/cimb45060288 · Cited by 41
Sharma, D., Gotlieb, N., Farkouh, M. E., Patel, K., Xu, W., & Bhat, M. (2022) · Journal of the American Heart Association · doi:10.1161/jaha.121.022576 · Cited by 36
“79 As shown in our study, it may be worth screening those individuals with early NAFLD who are present with certain clinical and genetic risk factors and could potentially benefit from early interventions that would prevent cardiovascular complications.”
Metadata
- Authors
- Kumar, R., Priyadarshi, R. N., & Anand, U.
- Venue
- Journal of Clinical and Translational Hepatology
- Publisher
- Xia & He Publishing
- Published
- 2019-12-28
- Volume
- X
- Issue
- X
- Pages
- 1-11
- ISSN
- 2225-0719 (ISSN-L)
- 2310-8819
- OpenAlex
- W2997437155
- Cited by
- 164
- References
- 121
- FWCI
- 13.74
- Type
- journal article
- Language
- en
- Open access
- diamond
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.